These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 38566316)

  • 1. Exploring promising minor natural phenolic compounds in neuroprotection-related preclinical models.
    Moreira Vasconcelos CF; Neugebauer AZ; Basto Souza R
    Basic Clin Pharmacol Toxicol; 2024 Jun; 134(6):770-777. PubMed ID: 38566316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Pharmacological Appraisal of Neuroprotective and Neurorestorative Flavonoids Against Neurodegenerative Diseases.
    Zhao J; Zhu M; Kumar M; Ngo FY; Li Y; Lao L; Rong J
    CNS Neurol Disord Drug Targets; 2019; 18(2):103-114. PubMed ID: 30394219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural Phenolic Compounds with Neuroprotective Effects.
    Tavan M; Hanachi P; de la Luz Cádiz-Gurrea M; Segura Carretero A; Mirjalili MH
    Neurochem Res; 2024 Feb; 49(2):306-326. PubMed ID: 37940760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential implications of polyphenolic compounds in neurodegenerative diseases.
    Shi R; Gao D; Stoika R; Liu K; Sik A; Jin M
    Crit Rev Food Sci Nutr; 2024; 64(16):5491-5514. PubMed ID: 36524397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotection of Coenzyme Q10 in Neurodegenerative Diseases.
    Yang X; Zhang Y; Xu H; Luo X; Yu J; Liu J; Chang RC
    Curr Top Med Chem; 2016; 16(8):858-66. PubMed ID: 26311425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin Receptor as a Drug Target for Neuroprotection.
    Wongprayoon P; Govitrapong P
    Curr Mol Pharmacol; 2021; 14(2):150-164. PubMed ID: 32316905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotection through flavonoid: Enhancement of the glyoxalase pathway.
    Frandsen JR; Narayanasamy P
    Redox Biol; 2018 Apr; 14():465-473. PubMed ID: 29080525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exendin-4: A potential therapeutic strategy for Alzheimer's disease and Parkinson's disease.
    Verma A; Chaudhary S; Solanki K; Goyal A; Yadav HN
    Chem Biol Drug Des; 2024 Jan; 103(1):e14426. PubMed ID: 38230775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithium and disease modification: A systematic review and meta-analysis in Alzheimer's and Parkinson's disease.
    Singulani MP; Ferreira AFF; Figueroa PS; Cuyul-Vásquez I; Talib LL; Britto LR; Forlenza OV
    Ageing Res Rev; 2024 Mar; 95():102231. PubMed ID: 38364914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in the Potential of Cannabinoids for Neuroprotection in Alzheimer's, Parkinson's, and Huntington's Diseases.
    Pérez-Olives C; Rivas-Santisteban R; Lillo J; Navarro G; Franco R
    Adv Exp Med Biol; 2021; 1264():81-92. PubMed ID: 33332005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effects of curcumin lipid-core nanocapsules in a model Alzheimer's disease induced by β-amyloid 1-42 peptide in aged female mice.
    Giacomeli R; Izoton JC; Dos Santos RB; Boeira SP; Jesse CR; Haas SE
    Brain Res; 2019 Oct; 1721():146325. PubMed ID: 31325424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenolic Acids and Prevention of Cognitive Decline: Polyphenols with a Neuroprotective Role in Cognitive Disorders and Alzheimer's Disease.
    Caruso G; Godos J; Privitera A; Lanza G; Castellano S; Chillemi A; Bruni O; Ferri R; Caraci F; Grosso G
    Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Potential Mechanisms of the Neuroprotective Actions of Oil Palm Phenolics: Implications for Neurodegenerative Diseases.
    Ibrahim N'; Muhammad Ismail Tadj NB; Rahman Sarker MM; Naina Mohamed I
    Molecules; 2020 Nov; 25(21):. PubMed ID: 33167585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychopharmacological neuroprotection in neurodegenerative disease: assessing the preclinical data.
    Lauterbach EC; Victoroff J; Coburn KL; Shillcutt SD; Doonan SM; Mendez MF
    J Neuropsychiatry Clin Neurosci; 2010; 22(1):8-18. PubMed ID: 20160205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases.
    Weinreb O; Mandel S; Amit T; Youdim MB
    J Nutr Biochem; 2004 Sep; 15(9):506-16. PubMed ID: 15350981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carvacrol as a Potential Neuroprotective Agent for Neurological Diseases: A Systematic Review Article.
    Zamanian MY; Kujawska M; Nikbakhtzadeh M; Hassanshahi A; Ramezanpour S; Kamiab Z; Bazmandegan G
    CNS Neurol Disord Drug Targets; 2021; 20(10):942-953. PubMed ID: 33970850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurodegeneration by oxidative stress: a review on prospective use of small molecules for neuroprotection.
    Singh E; Devasahayam G
    Mol Biol Rep; 2020 Apr; 47(4):3133-3140. PubMed ID: 32162127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Icariin: A Potential Neuroprotective Agent in Alzheimer's Disease and Parkinson's Disease.
    Khezri MR; Ghasemnejad-Berenji M
    Neurochem Res; 2022 Oct; 47(10):2954-2962. PubMed ID: 35802286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hesperidin as a Neuroprotective Agent: A Review of Animal and Clinical Evidence.
    Hajialyani M; Hosein Farzaei M; Echeverría J; Nabavi SM; Uriarte E; Sobarzo-Sánchez E
    Molecules; 2019 Feb; 24(3):. PubMed ID: 30759833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the potential of natural and synthetic neuroprotective steroids against neurodegenerative disorders: A literature review.
    Bansal R; Singh R
    Med Res Rev; 2018 Jul; 38(4):1126-1158. PubMed ID: 28697282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.